Inogen (INGN) Competitors $9.16 +0.13 (+1.44%) (As of 03:39 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends INGN vs. ZJYL, SMTI, LAKE, NTRB, APT, MLSS, COCH, RBOT, CLGN, and SPAIShould you be buying Inogen stock or one of its competitors? The main competitors of Inogen include Jin Medical International (ZJYL), Sanara MedTech (SMTI), Lakeland Industries (LAKE), Nutriband (NTRB), Alpha Pro Tech (APT), Milestone Scientific (MLSS), Envoy Medical (COCH), Vicarious Surgical (RBOT), CollPlant Biotechnologies (CLGN), and Safe Pro Group Inc. Common Stock (SPAI). These companies are all part of the "surgical appliances & supplies" industry. Inogen vs. Jin Medical International Sanara MedTech Lakeland Industries Nutriband Alpha Pro Tech Milestone Scientific Envoy Medical Vicarious Surgical CollPlant Biotechnologies Safe Pro Group Inc. Common Stock Jin Medical International (NASDAQ:ZJYL) and Inogen (NASDAQ:INGN) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, risk, earnings, media sentiment, profitability, dividends, valuation and institutional ownership. Does the media prefer ZJYL or INGN? In the previous week, Inogen had 2 more articles in the media than Jin Medical International. MarketBeat recorded 2 mentions for Inogen and 0 mentions for Jin Medical International. Inogen's average media sentiment score of 0.55 beat Jin Medical International's score of 0.00 indicating that Inogen is being referred to more favorably in the news media. Company Overall Sentiment Jin Medical International Neutral Inogen Positive Which has more risk and volatility, ZJYL or INGN? Jin Medical International has a beta of 16.25, suggesting that its share price is 1,525% more volatile than the S&P 500. Comparatively, Inogen has a beta of 1.04, suggesting that its share price is 4% more volatile than the S&P 500. Is ZJYL or INGN more profitable? Jin Medical International has a net margin of 0.00% compared to Inogen's net margin of -28.30%. Jin Medical International's return on equity of 0.00% beat Inogen's return on equity.Company Net Margins Return on Equity Return on Assets Jin Medical InternationalN/A N/A N/A Inogen -28.30%-45.37%-28.57% Which has preferable earnings and valuation, ZJYL or INGN? Jin Medical International has higher earnings, but lower revenue than Inogen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJin Medical International$19.82M15.56$2.88MN/AN/AInogen$315.66M0.68-$102.45M-$3.97-2.27 Do institutionals & insiders have more ownership in ZJYL or INGN? 89.9% of Inogen shares are held by institutional investors. 1.0% of Inogen shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts recommend ZJYL or INGN? Inogen has a consensus price target of $7.00, suggesting a potential downside of 22.48%. Given Inogen's higher possible upside, analysts clearly believe Inogen is more favorable than Jin Medical International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jin Medical International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AInogen 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the MarketBeat Community favor ZJYL or INGN? Inogen received 386 more outperform votes than Jin Medical International when rated by MarketBeat users. CompanyUnderperformOutperformJin Medical InternationalN/AN/AInogenOutperform Votes38669.68% Underperform Votes16830.32% SummaryInogen beats Jin Medical International on 8 of the 14 factors compared between the two stocks. Ad Weiss RatingsThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”Click here to find out more about what could be Trump and JD Vance’s favorite coin. Get Inogen News Delivered to You Automatically Sign up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INGN vs. The Competition Export to ExcelMetricInogenSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$214.19M$9.31B$5.10B$8.43BDividend YieldN/A1.10%7.52%4.16%P/E Ratio-2.2723.31133.4116.50Price / Sales0.6835.571,617.6575.90Price / CashN/A25.3937.2033.56Price / Book1.035.824.594.98Net Income-$102.45M$181.29M$116.16M$224.69M7 Day Performance-3.53%-3.99%-0.97%-0.51%1 Month Performance-0.99%-5.64%5.32%3.32%1 Year Performance69.42%2.29%33.76%25.51% Inogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INGNInogen2.5385 of 5 stars$9.10+0.8%$7.00-23.1%+69.4%$215.84M$326.65M-2.29834Upcoming EarningsZJYLJin Medical InternationalN/A$2.00-2.0%N/A-78.4%$310M$20.13M0.00245Positive NewsSMTISanara MedTech2.0861 of 5 stars$33.00+0.8%$44.00+33.3%+23.9%$288.75M$64.99M-42.3160Upcoming EarningsHigh Trading VolumeLAKELakeland Industries4.8787 of 5 stars$18.59-4.4%$26.50+42.5%+33.5%$137.57M$124.69M77.461,750Dividend AnnouncementGap DownHigh Trading VolumeNTRBNutriband0.755 of 5 stars$6.19+0.3%N/A+171.5%$68.77M$2.09M-7.6410Gap DownAPTAlpha Pro TechN/A$5.59+0.4%N/A+42.5%$62.44M$61.23M13.63120MLSSMilestone Scientific2.2348 of 5 stars$0.81+0.6%$1.25+55.3%-5.3%$62.17M$9.83M-11.5030Analyst ForecastCOCHEnvoy Medical3.565 of 5 stars$2.79+5.3%$7.92+183.8%+123.8%$54.68M$320,000.000.0034Gap DownHigh Trading VolumeRBOTVicarious Surgical1.9286 of 5 stars$7.91-2.5%$11.33+43.3%-32.5%$46.67MN/A-0.763Upcoming EarningsNews CoverageCLGNCollPlant Biotechnologies1.9265 of 5 stars$3.68-2.1%$11.00+198.7%-34.0%$42.16M$10.96M-2.3970Negative NewsHigh Trading VolumeSPAISafe Pro Group Inc. Common StockN/A$2.17-3.6%N/AN/A$30.08MN/A0.0011Gap Down Related Companies and Tools Related Companies Jin Medical International Alternatives Sanara MedTech Alternatives Lakeland Industries Alternatives Nutriband Alternatives Alpha Pro Tech Alternatives Milestone Scientific Alternatives Envoy Medical Alternatives Vicarious Surgical Alternatives CollPlant Biotechnologies Alternatives Safe Pro Group Inc. Common Stock Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:INGN) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredNASDAQ small cap that could be gearing up for a massive short squeeze.A Heavy Short Interest Could Lead to a Monstrous Short Squeeze for this Tiny NASDAQ Healthcare Firm!Huge Alerts | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inogen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.